Latest Breaking News On - Vipin garg - Page 1 : comparemela.com

Altimmune, Inc (NASDAQ:ALT) Q1 2024 Earnings Call Transcript

Altimmune, Inc (NASDAQ:ALT) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Yasmeen rahimiVipin gargScot robertsPiper sandlerScott harrisTechnology dividend aristocrats toAltimmune incCall transcript mayFirst quarterResults conferenceRich eisenstadtChief financial officerChief executive officerChief scientific officerChief medicalInvestor relations

3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024

Biotech stocks can offer some of the most explosive, exciting opportunities on the market.That is, if you find the right one.

Vipin gargMorgan stanleyDrug administrationFortress biotechJourney medicalNew drug applicationPrescription drug user fee actPriority review vouchersSilence therapeuticsChardan capital

Altimmune, Inc (NASDAQ:ALT) Q4 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to the Altimmune Inc. Full Year and Fourth Quarter 2023 Financial Results Conference Call.

Seamus fernandezScott harrisYasmeen rahimiPiper sandlerVipin gargLouis aronneScot robertsAltimmune incCall transcript marchFull yearFourth quarterResults conferenceRich eisenstadtChief financial officerBusiness update conferenceChief executive officer

Altimmune stock falls after obesity drug data (NASDAQ:ALT)

Altimmune stock falls after obesity drug data (NASDAQ:ALT)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesVipin gargUnited states recessionCrashing economy conceptEli lillyNovo nordisk

Ozempic And Wegovy Rivals: Here Are The Companies Working On Competitor Weight Loss Drugs

Ozempic maker Novo Nordisk and Mounjaro maker Eli Lilly dominate the lucrative weight loss drug market with Wegovy and Zepbound, but companies are racing to compete in one of the most lucrative markets in the history of the pharmaceutical industry.

San franciscoUnited statesUnited kingdomAlbert bourlaForbes lillyVipin gargZealand pharmaAltimmune gargEli lillyLilly mounjaroBoehringer ingelheimDrug administrationTerns pharmaceuticalsNovo nordiskDiego based viking therapeuticsmarkedStructure therapeutics